Christine Rohan

Christine Rohan is an accomplished executive with extensive experience in the healthcare and technology sectors. Currently serving as the Chief Executive Officer at Vasowatch, Christine leads initiatives to enhance risk assessment methods for postpartum hemorrhage, positively affecting 5% of all births. As an Advisory Board Member at Sharper Sense, Christine contributes to the development of wearable neurotechnology. In the role of Managing Partner at Inflection Point Advisory LLC, strategic collaborations with digital health enterprises are established to execute market entry strategies. Previously, as Chief Operating Officer at Renalis, Christine spearheaded commercialization efforts in pelvic health. At Blue Cross Blue Shield Association, significant digital health pipelines were generated under Christine's direction. Christine's prior experiences also include key positions at GE Capital and GE Transportation, where substantial growth strategies and customer experience enhancements were implemented. Christine holds an MBA from Harvard Business School and a BS in Industrial & Operations Engineering from the University of Michigan.